DexCare
Philadelphia, US · 5 known investors
DexCare provides patient access and scheduling navigation logic for health systems, enabling patients to find available appointments across multiple care entry points and improving utilization of existing capacity.
Also known as DexCare, Inc.
Investors · 5
Company profile
researched Aug 2026DexCare provides a patient navigation platform used by health systems to route patients across fragmented access points to care that is already available. The platform is organized into a data layer that structures providers, locations, schedules and visit types into a single source of truth; a navigation layer that weighs availability, clinical need, location and system priorities to determine where a patient should go; and an activation layer that executes those routing decisions across digital, assisted and operational touchpoints. Platform features include a rules engine for clinical and operational routing rules, matching and scoring across expertise, location, availability and capacity, workflow decisioning across primary, specialty, urgent and virtual care, AI agents for chat, voice and search, staff-facing AI assistance, and visual routing-logic building. Supporting services include a provider graph, provider data management (PDM+), AI-assisted ingestion and sync from EHRs, CRMs and credentialing systems, automated and claims-based data validation, access analytics, and bi-directional APIs.
Delivered as a platform-as-a-service, DexCare covers three core areas: care discovery, care booking and care delivery. Through integration with customer EMR systems the platform maintains a real-time view of available care resources and schedules, supporting provider-specific booking, provider-agnostic routing to the first available provider, and virtual visit wait-time checks. Booking is offered in scheduled mode (urgent care, provider-direct primary care, in-clinic or virtual appointments) and on-demand queued virtual mode, with white-label workflows that collect patient and caregiver details, billing information, visit details and consent. For care delivery, DexCare offers a customizable telemedicine system with WebRTC-based video, proxy booking, virtual hold with SMS and email support, and provider and management portals; its discovery and booking capabilities can also be used alongside third-party telemedicine systems. Developer-facing REST APIs and SDKs for iOS, Android and JavaScript allow health systems to build custom experiences.
Reported outcomes cited by the company include 40% more appointments without expanding staff rosters, a 30% increase in patient acquisition at Providence, quadrupled online scheduling at SSM Health, diversion of 350,000 emergency room hours and an eightfold increase in downstream revenue.
Founding story
DexCare originated inside Providence's Digital Innovation Group, which built the underlying platform in 2016 to support patient acquisition and navigation. The team says it launched from within Providence after observing that capacity existed but patients could not reach it, and that existing tools could schedule appointments but not route patients through system complexity. In the summer of 2020 the team wagered that care would remain multi-modal rather than fully virtual, which shaped the orchestration platform.
Business model
DexCare sells its navigation, scheduling and virtual care platform to health systems as a platform-as-a-service, integrating with customer EMR, CRM and credentialing systems and exposing REST APIs and mobile/JavaScript SDKs so customers can extend routing intelligence into call centers, apps, chat and other tools.
Traction
As of June 2023 the company reported serving more than 57 million patients across 50 states and partnering with numerous U.S. health systems including Kaiser Permanente, Providence and Community Health Network, with triple-digit annual recurring revenue growth cited by its CEO. Reported customer results include a 30% increase in net-new patient bookings, 350,000 emergency room hours diverted and an eightfold increase in downstream revenue.
Latest developments
The current platform emphasizes AI-enabled components, including agents for patient-facing chat, voice and search, an AI assist copilot for staff, AI-powered data ingestion and normalization, and visual routing-logic modeling, alongside PDM+ provider data governance and search/AI-answer visibility offerings. Leadership is now headed by CEO Matt Blosl.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
DexCare positions its navigation layer as distinct from directories, booking tools and provider data management systems, which it describes as able to list providers or schedule appointments but not govern routing rules across entry points. Investors cited its two-sided approach of consumer-grade care finding on the front end and capacity optimization for health systems on the back end.
The company differentiates on routing and decisioning logic rather than booking alone: shared navigation rules that execute consistently across all access points and replace spreadsheets and undocumented local knowledge, a governing layer above provider data management, and real-time EMR-integrated capacity balancing across providers, locations and modalities.
Technology
The platform integrates tightly with EMR systems to maintain real-time visibility of slot inventory and provider utilization, and uses an intelligent routing/decisioning engine that balances utilization across providers and locations. Architecture is modular, with intelligent services, integrated caching and capacity management, patient- and provider-facing web applications, REST APIs and iOS, Android and JavaScript SDKs, plus a WebRTC-based video system and external services for telecommunications, billing, authentication, monitoring, deployment and analytics. Newer components use AI for data ingestion, mapping, enrichment and normalization, patient-facing chat, voice and search agents, staff copilot functionality and routing-logic modeling.
Go-to-market
The company markets directly to health system leadership, using free branded interactive search-and-schedule demo environments built from a prospect's website, published customer case studies (SSM Health, Providence, MUSC, University of Rochester, Texas Health Resources), and downloadable playbooks on SEO/AEO strategy, provider data management and regional market share analysis.
Hospitals and health systems, including large multi-site and multi-modality organizations managing primary, specialty, urgent and virtual care access; named customers and referenced organizations include Kaiser Permanente, Providence, Community Health Network, SSM Health, MUSC, Texas Health Resources and University of Rochester.
Geography
Operates across the United States, with reported patient coverage in 50 states; published market analysis covers health systems in Pennsylvania, New Jersey and Delaware.
History
The platform was developed at Providence beginning in 2016 and spun out as DexCare, which launched in 2021 during the COVID-19 pandemic; Derek Streat joined as CEO in April 2020. It was the third health-related business spun out of Providence's Digital Innovation Group, after Xealth and Circle. DexCare acquired Womp in 2022 to bring eCommerce practices into healthcare. It closed a $50 million Series B in December 2021 (announced January 2022) and a $75 million Series C announced in June 2023, bringing total funding to $146 million. The company is currently led by CEO Matt Blosl, with co-founder and president Sean O'Connor and a board including investors from Define Ventures, Transformation Capital, ICONIQ, Allumia Ventures and Frist Cressey Ventures (observer).
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 6
launches, deals, and filingsDexCare closed a $75 million Series C round to accelerate market expansion of its patient demand and care access platform, bringing total funding to $146 million. ICONIQ Growth led, with participation from Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures and SpringRock Ventures. The CEO declined to disclose the valuation but said it was a healthy increase over the Series B.
$75M source ↗
DexCare acquired Womp to bring eCommerce practices into healthcare patient access.
DexCare closed a $50 million Series B in December 2021 and announced it in January 2022; coverage referenced Kaiser Permanente and Mass General backing the Providence spinoff's round.
$50M source ↗
DexCare launched in 2021, spun out of Providence; Providence's Digital Innovation Group had developed the platform beginning in 2016 for patient acquisition and navigation. DexCare was the group's third health-related spinout after Xealth and Circle.
Derek Streat joined DexCare as chief executive officer in April 2020.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 8
primary sources listed
- DexCaredexcarehealth.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does DexCare do?
- DexCare is a patient navigation and care access platform that routes and books patients into available health system capacity.
- Who are DexCare's investors?
- DexCare's investors include Frist Cressey Ventures, Kaiser Permanente Ventures, SPRINGROCK VENTURES, TRANSFORMATION CAPITAL, Define Ventures.
- Where is DexCare headquartered?
- DexCare is headquartered in Philadelphia, US.